Among markers of highest specificity for cluster 11, we have identified FOXM1, known to be involved in the regulation of quiescence and stemness potential in the hematopoietic compartment24 and frequently dysregulated in malignancies (glioma, leukemia, and colon cancer)25,26. Here, FOXM1 is linked to central nervous system cancer.